Principal Financial Group Inc Forma Therapeutics Holdings, Inc. Transaction History

Principal Financial Group Inc

  • $1.66 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$13.6 - $24.89 $120,890 - $221,247
-8,889 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$21.22 - $25.7 $30,578 - $37,033
-1,441 Reduced 13.95%
8,889 $206,000
Q2 2021

Aug 10, 2021
BUY
$22.86 - $30.95 $27,294 - $36,954
1,194 Added 13.07%
10,330 $257,000
Q1 2021

May 10, 2021
BUY
$24.58 - $42.82 $15,829 - $27,576
644 Added 7.58%
9,136 $256,000
Q4 2020

Feb 08, 2021
BUY
$34.9 - $51.08 $296,370 - $433,771
8,492 New
8,492 $296,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email